WMSA
TGTX icon

Weiss Multi-Strategy Advisers’s TG Therapeutics TGTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$87K – 699
2019
Q2 		$87K Sell
10,000
-5,000
-33% -$37.8K ﹤0.01% 478
2019
Q1 		$121K Buy
+15,000
New +$81.1K ﹤0.01% 488

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TGTX Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of TG Therapeutics (TGTX) in Q1 2024, closing a stake of 60,000 shares — an estimated $1.02M sold.

Weiss Multi-Strategy Advisers first reported a position in TGTX in Q2 2014 and held it in 15 quarters. The position peaked at $1.02M in Q4 2023. 243 funds tracked by Wall St. Rank hold TGTX as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining TG Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 60,000 TG Therapeutics shares in Q1 2024, an estimated $1.02M.
  • Weiss Multi-Strategy Advisers first reported a position in TG Therapeutics in Q2 2014 and held it in 15 quarters.
  • Weiss Multi-Strategy Advisers's TG Therapeutics position peaked at $1.02M in Q4 2023.
  • 243 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.